Cell Biotech Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Cell Biotech Co Ltd

Watchlist Manager

Watchlist

Price: 14 760 KRW -0.87% Market Closed

Market Cap: ₩101B

C	Cell Biotech Co Ltd KOSDAQ:049960	KR
S	Spaceandpeople PLC LSE:SAL	UK
	United Internet AG OTC:UDIRY	DE
M	Madrigal Pharmaceuticals Inc F:YDO1	US
U	United Internet AG OTC:UDIRF	DE

Profitability Summary

Cell Biotech Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

73%

Strong 3Y Average Gross Margin

72%

Declining Gross Margin

74% > 73%

Healthy Operating Margin

17%

Sustainable 3Y Average Operating Margin

13%

Operating Margin is Increasing

2% > 17%

Healthy Net Margin

28%

Sustainable 3Y Average Net Margin

22%

Net Margin is Increasing

0% > 28%

Exceptional Free Cash Flow Margin

18%

Strong 3Y Average Free Cash Flow Margin

22%

Free Cash Flow Margin is Increasing

Positive 3Y Average ROIC

14%

ROIC is Increasing

0% > 19%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.